Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Contribution entitled
"The Cost-effectiveness of Preventing AIDS-Related Opportunistic
Infections" published in the January 14, 1998, issue of THE
JOURNAL (1998;279:130-136), the cost-effectiveness
ratios in dollars for Pneumocystis carinii pneumonia and
toxoplasmosis prophylaxis were incorrect. In Table 3 on page 133, the
ratio should be 2300 (not 16,000) per quality-adjusted life-year
saved. In Table 4 on page 134, in the analyses unadjusted for quality
of life and assuming combination antiretroviral therapy, the ratios
should be 1900 (not 13,000) per year of life saved; and
10,200 (not 22,000) per quality-adjusted life-year saved,
respectively. In Table 6 on page 134, the ratio for strategy 2 should
be 2300 (not 16,000) per quality-adjusted life-year saved. The
revised data do not affect the article's policy conclusions.
Incorrect Data. JAMA. 1999;281(21):1989. doi:10.1001/jama.281.21.1989